As mentioned, PAD4, the histone-citrullinating enzyme, has also been found to be overexpressed in various tumors, whereas no PAD4 expression was found in benign tumors and non-cancerous inflamed tissue samples [21], suggesting abnormal PAD4 activity/citrullination in tumor cells. This evidence concerns the gene PADI4 and benign neoplasm.